Table 1 Baseline and Laboratory characteristics of studied groups.

From: Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients

Parameters

Cases (N = 50) Mean ± SD

Controls (N = 50) Mean ± SD

p value

Age (years) Mean + standard deviation (SD)

45.40 ± 12.5

45.12 ± 11.5

0.907

Male

28 (56%)

30 (60%)

0.420

Female

22 (44%)

20 (40%)

 

Nonsmoker

37 (74%)

38 (76%)

0.817

Smoker

13 (26%)

12 (24%)

 

Body mass index(BMI)

27.85 ± 5.4

27.77 ± 5.5

0.941

Hemoglobin concentration (g/dl)

12.79 ± 1.2

12.71 ± 1.3

0.41

White blood cells *103/µL

38.08 ± 10.6

36.09 ± 11.4

0.37

Red blood cells (106/mm3)

4.91 ± 0.9

5.01 ± 1.0

0.9

Platelet *103/µL

270.91 ± 13.3

288.46 ± 16.2

0.76

Mean corpuscular volume (M CV) (fl)

83.95 ± 9.0

83.78 ± 8.9

0.072

Mean Corpuscular Haemoglobin (MCH) (pg)

28.43 ± 4.1

27.65 ± 1.8

0.13

Triglycerides (mg/dl)

162.12 ± 12.3

163.66 ± 10.4

0.929

Total cholesterol (mg/dl)

183.22 ± 8.4

176.64 ± 7.5

0.560

Erythrocyte sedimentation rate (ESR) (mm/hr)

21.44 ± 1.8

22.60 ± 1.9

0.661

Alanine transferase (IU/L)

31.52 ± 2.5

23.62 ± 1.4

0.003

Aspartate transferase (AST) (IU/L)

30.58 ± 2.1

28.60 ± 2.3

0.252

Albumin (g/L)

4.17 ± 0.5

4.15 ± 0.5

0.868

Total Protein (g/dl)

7.17 ± 0.7

7.29 ± 0.7

0.382

Total Bilirubin (mg/dl)

0.64 ± 0.1

0.65 ± 0.1

0.929

Direct Bilirubin (mg/dl)

0.22 ± 0.1

0.21 ± 0.1

0.820

International normalized ratio (INR)

1.10 ± 0.1

1.11 ± 0.2

0.770

Urea (mg/dl)

34.22 ± 10.8

31.34 ± 10.5

0.179

Creatinine (mg/dl)

0.90 ± 0.1

0.82 ± 0.1

0.142

Fasting blood sugar (FBG) (mg/dl)

98.94 ± 16.3

97.14 ± 15.6

0.589

Fasting Insulin (mIU/L)

4.50 ± 0.4

4.03 ± 0.3

0.380

HOMA-IR, median (range)

0.96 (0.329–2.24)

0.827 (0.19–3.26)

0.326

  1. HOMA-IR homeostasis model assessment of insulin resistance.